194 related articles for article (PubMed ID: 11175813)
1. Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells.
Cerutti A; Kim EC; Shah S; Schattner EJ; Zan H; Schaffer A; Casali P
Nat Immunol; 2001 Feb; 2(2):150-6. PubMed ID: 11175813
[TBL] [Abstract][Full Text] [Related]
2. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
3. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.
Cerutti A; Zan H; Kim EC; Shah S; Schattner EJ; Schaffer A; Casali P
J Immunol; 2002 Dec; 169(11):6594-603. PubMed ID: 12444172
[TBL] [Abstract][Full Text] [Related]
4. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells.
Cerutti A; Schaffer A; Shah S; Zan H; Liou HC; Goodwin RG; Casali P
Immunity; 1998 Aug; 9(2):247-56. PubMed ID: 9729045
[TBL] [Abstract][Full Text] [Related]
5. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro.
Malisan F; Fluckiger AC; Ho S; Guret C; Banchereau J; Martinez-Valdez H
Blood; 1996 Jan; 87(2):717-24. PubMed ID: 8555496
[TBL] [Abstract][Full Text] [Related]
6. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
[TBL] [Abstract][Full Text] [Related]
7. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.
He B; Qiao X; Klasse PJ; Chiu A; Chadburn A; Knowles DM; Moore JP; Cerutti A
J Immunol; 2006 Apr; 176(7):3931-41. PubMed ID: 16547227
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.
Cerutti A; Zan H; Schaffer A; Bergsagel L; Harindranath N; Max EE; Casali P
J Immunol; 1998 Mar; 160(5):2145-57. PubMed ID: 9498752
[TBL] [Abstract][Full Text] [Related]
10. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination.
Zan H; Cerutti A; Dramitinos P; Schaffer A; Casali P
J Immunol; 1998 Nov; 161(10):5217-25. PubMed ID: 9820493
[TBL] [Abstract][Full Text] [Related]
11. Regulation of murine B cell growth and differentiation by CD30 ligand.
Shanebeck KD; Maliszewski CR; Kennedy MK; Picha KS; Smith CA; Goodwin RG; Grabstein KH
Eur J Immunol; 1995 Aug; 25(8):2147-53. PubMed ID: 7664777
[TBL] [Abstract][Full Text] [Related]
12. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.
He B; Raab-Traub N; Casali P; Cerutti A
J Immunol; 2003 Nov; 171(10):5215-24. PubMed ID: 14607922
[TBL] [Abstract][Full Text] [Related]
13. Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.
Zan H; Cerutti A; Dramitinos P; Schaffer A; Li Z; Casali P
J Immunol; 1999 Mar; 162(6):3437-47. PubMed ID: 10092799
[TBL] [Abstract][Full Text] [Related]
14. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
15. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
17. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
18. IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia.
de Totero D; Reato G; Mauro F; Cignetti A; Ferrini S; Guarini A; Gobbi M; Grossi CE; Foa R
Br J Haematol; 1999 Mar; 104(3):589-99. PubMed ID: 10086799
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
20. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
